Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, April 2008, p. 1252-1256, Vol. 52, No. 4
0066-4804/08/$08.00+0 doi:10.1128/AAC.01304-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Acinetobacter radioresistens as a Silent Source of Carbapenem Resistance for Acinetobacter spp.
Laurent Poirel,1
Samy Figueiredo,1
Vincent Cattoir,1
Alessandra Carattoli,2 and
Patrice Nordmann1*
Service de Bactériologie-Virologie, INSERM U914, Emerging Resistance to Antibiotics, Hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Université Paris XI, Le Kremlin-Bicêtre, France,1
Department of Infectious, Parasitic and Immune-Mediated Diseases, Istituto Superiore di Sanita, Rome, Italy2
Received 10 October 2007/
Returned for modification 14 November 2007/
Accepted 4 January 2008
Carbapenem resistance results mostly from the expression of acquired carbapenem-hydrolyzing oxacillinases in Acinetobacter baumannii. The blaOXA-23 oxacillinase gene is increasingly reported worldwide and may represent an emerging threat. Our goal was to identify the progenitor of that carbapenemase gene. A collection of 50 Acinetobacter sp. strains corresponding to several Acinetobacter species was screened for blaOXA-23-like genes by PCR and hybridization techniques. Five Acinetobacter radioresistens isolates that were susceptible to carbapenems harbored chromosomally encoded blaOXA-23-like genes. A similar plasmid backbone was identified in several blaOXA-23-positive A. baumannii and A. radioresistens isolates, further strengthening the vectors of exchanges for these blaOXA-23-like genes. Therefore, A. radioresistens, a commensal bacterial species which is identified on the skin of hospitalized and healthy patients (a property shared with A. baumannii), was identified as the source of the blaOXA-23 gene.
* Corresponding author. Mailing address: Service de Bactériologie-Virologie, Hôpital de Bicêtre, 78 rue du Général Leclerc, Le Kremlin-Bicêtre 94275, France. Phone: 33-1-45-21-36-32. Fax: 33-1-45-21-63-40. E-mail:
nordmann.patrice{at}bct.aphp.fr
Published ahead of print on 14 January 2008.
Antimicrobial Agents and Chemotherapy, April 2008, p. 1252-1256, Vol. 52, No. 4
0066-4804/08/$08.00+0 doi:10.1128/AAC.01304-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Higgins, P. G., Poirel, L., Lehmann, M., Nordmann, P., Seifert, H.
(2009). OXA-143, a Novel Carbapenem-Hydrolyzing Class D {beta}-Lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother.
53: 5035-5038
[Abstract]
[Full Text]
-
Livermore, D. M.
(2009). Has the era of untreatable infections arrived?. J Antimicrob Chemother
64: i29-i36
[Abstract]
[Full Text]
-
Boo, T. W., Crowley, B.
(2009). Detection of blaOXA-58 and blaOXA-23-like genes in carbapenem-susceptible Acinetobacter clinical isolates: should we be concerned?. J Med Microbiol
58: 839-841
[Full Text]
-
Mendes, R. E., Bell, J. M., Turnidge, J. D., Castanheira, M., Deshpande, L. M., Jones, R. N.
(2009). Codetection of blaOXA-23-Like Gene (blaOXA-133) and blaOXA-58 in Acinetobacter radioresistens: Report from the SENTRY Antimicrobial Surveillance Program. Antimicrob. Agents Chemother.
53: 843-844
[Full Text]
-
Mendes, R. E., Bell, J. M., Turnidge, J. D., Castanheira, M., Jones, R. N.
(2009). Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program. J Antimicrob Chemother
63: 55-59
[Abstract]
[Full Text]
-
Adams-Haduch, J. M., Paterson, D. L., Sidjabat, H. E., Pasculle, A. W., Potoski, B. A., Muto, C. A., Harrison, L. H., Doi, Y.
(2008). Genetic Basis of Multidrug Resistance in Acinetobacter baumannii Clinical Isolates at a Tertiary Medical Center in Pennsylvania. Antimicrob. Agents Chemother.
52: 3837-3843
[Abstract]
[Full Text]